Panagora Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-145,526
| Closed | -$799K | – | 1226 |
|
|
2025
Q1 | $799K | Buy |
+145,526
| New | +$799K | ﹤0.01% | 705 |
|
|
2024
Q1 | – | Sell |
-140,318
| Closed | -$330K | – | 1269 |
|
|
2023
Q4 | $330K | Sell |
140,318
-109,882
| -44% | -$258K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $465K | Sell |
250,200
-37,400
| -13% | -$69.6K | ﹤0.01% | 990 |
|
|
2023
Q2 | $754K | Buy |
+287,600
| New | +$754K | ﹤0.01% | 874 |
|
|
2021
Q2 | – | Sell |
-2,576
| Closed | -$12K | – | 2974 |
|
|
2021
Q1 | $12K | Hold |
2,576
| – | – | ﹤0.01% | 2369 |
|
|
2020
Q4 | $13K | Sell |
2,576
-5,829
| -69% | -$29.4K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $50K | Hold |
8,405
| – | – | ﹤0.01% | 2017 |
|
|
2020
Q2 | $22K | Hold |
8,405
| – | – | ﹤0.01% | 2128 |
|
|
2020
Q1 | $16K | Buy |
+8,405
| New | +$16K | ﹤0.01% | 2082 |
|